Armata Pharmaceuticals Inc (ARMP) Stock: A Closer Look

At the time of writing, Armata Pharmaceuticals Inc [ARMP] stock is trading at $2.07, saw in change for the day. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ARMP shares have gain 11.89% over the last week, with a monthly amount drifted -5.48%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Armata Pharmaceuticals Inc [AMEX: ARMP] stock has seen the most recent analyst activity on June 19, 2019, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $9.

For the past year, the stock price of Armata Pharmaceuticals Inc fluctuated between $1.80 and $4.48. Armata Pharmaceuticals Inc [AMEX: ARMP] shares were valued at $2.07 at the most recent close of the market.

Analyzing the ARMP fundamentals

According to Armata Pharmaceuticals Inc [AMEX:ARMP], the company’s sales were 5.47M for trailing twelve months, which represents an 142.69% jump. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -16.63%, Pretax Profit Margin comes in at -16.59%, and Net Profit Margin reading is -16.59%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is 0.89 and Total Capital is 2.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-2.11.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.98 points at the first support level, and at 1.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.22, and for the 2nd resistance point, it is at 2.37.

Ratios To Look Out For

It is important to note that Armata Pharmaceuticals Inc [AMEX:ARMP] has a current ratio of 0.19. Also, the Quick Ratio is 0.19, while the Cash Ratio stands at 0.15. Considering the valuation of this stock, the price to sales ratio is 13.69.

Related Posts